RE: 100,000 yearly tests in UK, 300,000 in US30 Mar 2023 09:27
NICE, whose guidance is formally applicable to the NHS in England and Wales, is an internationally respected health authority and the tools and data supplied in its review will be relevant to the rest of the United Kingdom and to the other international markets which we are now accessing.”
This is what's important...eyes on the prize all LTH's. Not the day traders.
By the way the share price is irrelevant to the Company. DB already said ..finance from elsewhere, they are not idiots